clinical_frontiers revision_clean 050923

Healthy SGRQ Activity Score Week 4 – Baseline Healthy SGRQ Impact Score Week 4 – Baseline Asthma SGRQ Total Score Week 4 – Baseline

-0.753

4.789 1.444 -3.970

2.465

-0.521 10 0.614

-0.468

2.623 0.791 -2.230

1.294

-0.592 10 0.567

-3.594

7.967 2.402 -8.946

1.758

-1.496 10 0.165

Asthma SGRQ Symptom Score Week 4 – Baseline

-10.012 20.628 6.220 -23.870 2.846

-1.610 10 0.139

Asthma SGRQ Activity Score Week 4 – Baseline Asthma SGRQ Impact Score Week 4 – Baseline

1.333

10.153 3.061 -5.487

8.154

-.436

10 0.672

-4.451

7.118 2.146 -9.233

0.330

-2.074 10 0.065

383

384

385

7

Conflict of Interest

ResBiotic Nutrition Inc is a university startup out of the University of Alabama at Birmingham of 386 which Dr. Lal is the Founder, Dr. Gaggar is the Chief Medical Officer, and Dr. Ambalavanan and Dr. 387 Willis are Advisors. 388

389

8

Author Contributions

Study conception and strategy: CVL. Study design: NMW, LQ, TN, ZN, XX, AG, CVL. Manuscript 390 preparation and interpretation: NMW, TN, KAW, NA, AG, CVL, BAH. Clinical trial design and 391 execution: NMW, TD, AG, CVL. Clinical data analysis: TN, ZN, LQ, GD, CK, AG, CVL, BAH, 392 KT, ME, IM. All authors reviewed, advised, and approved the final version submitted for publication 393 and agree to be accountable for the work. 394

395

9

Funding

Research reported in this article was supported by the National Heart, Lung and Blood Institute of the 396 National Institutes of Health under award number K08 HL141652 (CVL) and K08 HL151907 397 (KAW). resB Lung Support for clinical trial use was gifted by ResBiotic Nutrition, Inc. 398

14

This is a provisional file, not the final typeset article

Powered by